Quick Takeaways
- Fung Ching Wong filed SCHEDULE 13D/A for LakeShore Biopharma Co., Ltd. Ordinary Shares, par value $0.0002 per share (LSB).
- Disclosed ownership: 24%.
- Date of event: 11 Jul 2025.
Fung Ching Wong - 11 Jul 2025 SCHEDULE 13D/A Report for LakeShore Biopharma Co., Ltd. Ordinary Shares, par value $0.0002 per share (LSB)
- Filing Manager
- Fung Ching Wong
- Reporting Manager
- Fung Ching Wong
- Symbol
- LSB
- Shares outstanding
- 41,154,854 shares
- Disclosed Ownership
- 9,836,010 shares
- Ownership
- 24%
- Form type
- SCHEDULE 13D/A
- Filing time
- 15 Jul 2025, 16:01:18 UTC
- Date of event
- 11 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Fung Ching Wong disclosed 24% ownership in LakeShore Biopharma Co., Ltd. Ordinary Shares, par value $0.0002 per share (LSB) on 11 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Jul 2025, 16:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Fung Ching Wong | 24% | 9,836,010 | 0 | 9,836,010 | /s/ Fung Ching Wong | Fung Ching Wong | 0002011156 |
| Apex Prospect Limited | 24% | 9,836,010 | 0 | 9,836,010 | /s/ Fung Ching Wong | Fung Ching Wong, Director |